Aromatase: Biologic Relevance of Tissue-Specific Expression

 

 Buy Article Permissions and Reprints

Aromatase P450 (P450arom) catalyzes the formation of estrogen in several human tissues under the control of alternatively used promoters. Each promoter is regulated by a distinct signaling pathway in a tissue- and hormone-specific manner. This article reviews these regulatory mechanisms in the ovary, adipose tissue, placenta, bone, brain, and various malignant cells. Moreover, the physiological and pathologic impacts of local estrogen biosynthesis in contrast to circulating estrogen or estrogen-responsive human tissues are discussed.

REFERENCES

• 1 Nelson D R, Koymans L, Kamataki T et al.. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.  Pharmacogenetics. 1996;  6 1-42
  CrossrefPubMedGoogle Scholar
• 2 Means G D, Mahendroo M, Corbin C J et al.. Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis.  J Biol Chem. 1989;  264 19385-19391
  PubMedGoogle Scholar
• 3 Harada N, Yamada K, Saito K, Kibe N, Dohmae S, Takagi Y. Structural characterization of the human estrogen synthetase (aromatase) gene.  Biochem Biophys Res Commun. 1990;  166 365-372
  CrossrefPubMedGoogle Scholar
• 4 Toda K, Terashima M, Kamamoto T et al.. Structural and functional characterization of human aromatase P450 gene.  Eur J Biochem. 1990;  193 559-565
  CrossrefPubMedGoogle Scholar
• 5 Means G D, Kilgore M W, Mahendroo M S, Mendelson C R, Simpson E R. Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues.  Mol Endocrinol. 1991;  5 2005-2013
  PubMedGoogle Scholar
• 6 Mahendroo M S, Means G D, Mendelson C R, Simpson E R. Tissue-specific expression of human P450_arom: the promoter responsible for expression in adipose is different from that utilized in placenta.  J Biol Chem. 1991;  266 11276-11281
  PubMedGoogle Scholar
• 6a Sebastian S, Bulun S E. A highly complex organization of the regulatory region of the human CYP19 (aromatase) gene revealed by the Human Genome Project.  J Clin Endocrinol Metab. 2001;  86 4600-4602
  CrossrefPubMedGoogle Scholar
• 7 Jenkins C, Michael D, Mahendroo M, Simpson E. Exon-specific northern analysis and rapid amplification of cDNA ends (RACE) reveal that the proximal promoter II (PII) is responsible for aromatase cytochrome P450 (CYP19) expression in human ovary.  Mol Cell Endocrinol. 1993;  97 R1-R6
  CrossrefPubMedGoogle Scholar
• 8 Mahendroo M S, Mendelson C R, Simpson E R. Tissue-specific and hormonally-controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue.  J Biol Chem. 1993;  268 19463-19470
  PubMedGoogle Scholar
• 9 Honda S, Harada N, Takagi N. Novel exon I of the aromatase gene specific for aromatase transcripts in human brain.  Biochem Biophys Res Commun. 1994;  198 1153-1160
  CrossrefPubMedGoogle Scholar
• 10 Shozu M, Zhao Y, Bulun S E, Simpson E R. Multiple splicing events involved in regulation of human aromatase expression by a novel promoter, I.6  Endocrinology. 1998;  139 1610-1617
  CrossrefPubMedGoogle Scholar
• 11 Simpson E R, Zhao Y, Agarwal V R et al.. Aromatase expression in health and disease.  Recent Prog Horm Res. 1997;  52 185-214
  PubMedGoogle Scholar
• 12 Callard G V, Petro Z, Ryan K J. Phylogenetic distribution of aromatase and other androgen-converting enzymes in the central nervous system.  Endocrinology. 1978;  103 2283-2290
  PubMedGoogle Scholar
• 13 Callard G V, Petro Z, Ryan K J. Aromatization and 5α-reduction in brain and non-neural tissues of a cyclostome (Petromyzan marinua).  Gen Comp Endocrinol. 1980;  42 155-159
  CrossrefPubMedGoogle Scholar
• 14 Callard G V. Aromatization is cyclic AMP-dependent in cultured reptilian brain cells.  Brain Res. 1981;  204 451-454
  CrossrefPubMedGoogle Scholar
• 15 Hutchinson J B. Hormonal control of behaviour: steroid action in the brain.  Curr Opin Neurobiol. 1991;  1 562-570
  PubMedGoogle Scholar
• 16 Michael M D, Kilgore M W, Morohashi K, Simpson E R. Ad4BP/SF-1 regulates cyclic AMP-induced transcription from the proximal promoter (PII) of the human aromatase P450 (CYP19) gene in the ovary.  J Biol Chem. 1995;  270 13561-13566
  CrossrefPubMedGoogle Scholar
• 17 Fitzpatrick S L, Richards J S. Identification of a cyclic adenosine 3′,5′-monophosphate-response element in the rat aromatase promoter that is required for transcriptional activation in rat granulose cells and R2C leydig cells.  Mol Endocrinol. 1994;  8 1309-1319
  CrossrefPubMedGoogle Scholar
• 18 Luo X, Ikeda Y, Parker K L. A cell-specific nuclear receptor is essential for adrenal and gonadal development.  Cell. 1994;  77 481-490
  CrossrefPubMedGoogle Scholar
• 19 Lala D S, Rice D A, Parker K L. Steroidogenic factor 1, a key regulation of steroidogenic gene expression, is the mouse homolog of fushi tarazu-factor 1.  Mol Endocrinol. 1992;  6 1249-1258
  CrossrefPubMedGoogle Scholar
• 20 Michael M D, Michael L F, Simpson E R. A CRE-like sequence that binds CREB and contributes to cAMP-dependent regulation of the proximal promoter of the human aromatase P450 (CYP19) gene.  Mol Cell Endocrinol. 1997;  134 147-156
  CrossrefPubMedGoogle Scholar
• 21 Hinshelwood M M, Michael M D, Simpson E R. The 5′-flanking region of the ovarian promoter of the bovine CYP19 gene contains a deletion in a cyclicadenosine 3′,5′-monophosphate-like responsive sequence.  Endocrinology. 1997;  138 3704-3710
  CrossrefPubMedGoogle Scholar
• 22 Zhao Y, Mendelson C R, Simpson E R. Characterization of the sequences of the human CYP19 (aromatase) gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes.  Mol Endocrinol. 1995;  9 340-349
  CrossrefPubMedGoogle Scholar
• 23 Zhao Y, Nichols J E, Bulun S E, Mendelson C R, Simpson E R. Aromatase P450 gene expression in human adipose tissue: role of a Jak/STAT pathway in regulation of the adipose-specific promoter.  J Biol Chem. 1995;  270 16449-16457
  CrossrefPubMedGoogle Scholar
• 24 Reichardt H M, Schutz G. Glucocorticoid signalling: multiple variations of a common theme.  Mol Cell Endocrinol. 1998;  146 1-6
  CrossrefPubMedGoogle Scholar
• 25 Price T, O'Brien S, Dunaif A, Simpson E R. Comparison of aromatase cytochrome P450 mRNA levels in adipose tissue from the abdomen and buttock using competitive polymerase chain reaction amplification.  Proc Soc Gynecol Invest. 1992;  1 179
  PubMedGoogle Scholar
• 26 Berkovitz G D, Bisat T, Carter K M. Aromatase activity in microsomal preparations of human genital skin fibroblasts: influence of glucocorticoids.  J Steroid Biochem. 1989;  33 341-347
  CrossrefPubMedGoogle Scholar
• 27 Bruch H R, Wolf L, Budde R, Romalo G, Schweikert H U. Androstenedione metabolism in cultured human osteoblast-like cells.  J Clin Endocrinol Metab. 1992;  75 101-105
  CrossrefPubMedGoogle Scholar
• 28 Nawata H, Tanaka S, Tanaka S et al.. Aromatase in bone cell: association with osteoporosis in postmenopausal women.  J Steroid Biochem Mol Biol. 1995;  53 165-174
  CrossrefPubMedGoogle Scholar
• 29 Harada N, Utsume T, Takagi Y. Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis.  Proc Natl Acad Sci USA. 1993;  90 11312-11316
  PubMedGoogle Scholar
• 30 Agarwal V R, Bulun S E, Leitch M, Rohrich R, Simpson E R. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.  J Clin Endocrinol Metab. 1996;  81 3843-3849
  CrossrefPubMedGoogle Scholar
• 31 Zhao Y, Agarwal V R, Mendelson C R, Simpson E R. Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE₂ via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene.  Endocrinology. 1996;  137 5739-5742
  CrossrefPubMedGoogle Scholar
• 32 Agarwal V R, Ashanullah C I, Simpson E R, Bulun S E. Alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in adipose tissue of women.  J Clin Endocrinol Metab. 1997;  82 70-74
  CrossrefPubMedGoogle Scholar
• 33 Bulun S E, Simpson E R. Competitive RT-PCR analysis indicates levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increase with advancing age.  J Clin Endocrinol Metab. 1994;  78 428-432
  CrossrefPubMedGoogle Scholar
• 34 Wei J, Xu H, Davies J L, Hemmings J P. Increase of plasma IL-6 concentration with age in healthy subjects.  Life Sci. 1992;  51 1953-1956
  CrossrefPubMedGoogle Scholar
• 35 Daynes R A, Araneo B A, Ershler W B, Maloney C, Li G Z, Ryu S Y. Altered regulation of IL-6 production with normal aging.  J Immunol. 1993;  150 5219-5230
  PubMedGoogle Scholar
• 36 Petruschke T, Hauner H. Tumor necrosis factor-alpha prevents the differentiation of human adipocyte precursor cells and caused delipidation of developed fat cells.  J Clin Endocrinol Metab. 1993;  76 742-747
  CrossrefPubMedGoogle Scholar
• 37 Kawashima I, Ohsumi J, Mita-Honjo K et al.. Molecular cloning of cDNA encoding adipogenesis inhibitory factor and identity with interleukin-11.  FEBS Lett. 1991;  283 199-202
  CrossrefPubMedGoogle Scholar
• 38 Kliewer S A, Lenhard J M, Willson T M, Patel I, Morris D C, Lehmann J M. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation.  Cell. 1995;  83 813-819
  CrossrefPubMedGoogle Scholar
• 39 Rubin G L, Zhao Y, Kalus A M, Simpson E R. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.  Cancer Res. 2000;  60 1604-1608
  PubMedGoogle Scholar
• 40 Rink J D, Simpson E R, Barnard J J, Bulun S E. Cellular chacterization of adipose tissue from various body sites of women.  J Clin Endocrinol Metab. 1996;  81 2443-2447
  CrossrefPubMedGoogle Scholar
• 41 Bulun S E, Sharda G, Rink J, Sharma S, Simpson E R. Distribution of aromatase P450 transcripts and adipose fibroblasts in the human breast.  J Clin Endocrinol Metab. 1996;  81 1273-1277
  CrossrefPubMedGoogle Scholar
• 42 Harada N. Aberrant expression of aromatase in breast cancer tissues.  J Steroid Biochem Mol Biol. 1997;  61 175-184
  CrossrefPubMedGoogle Scholar
• 43 Zhou D, Zhou C, Chen S. Gene regulation studies of aromatase expression in breast cancer and adipose stromal cells.  J Steroid Biochem Mol Biol. 1997;  61 273-280
  CrossrefPubMedGoogle Scholar
• 44 Zhou J, Gurates B, Yang S, Sebastian S, Bulun S E. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.  Cancer Res. 2001;  61 2328-2334
  PubMedGoogle Scholar
• 45 Meng L, Zhou J, Sasano H, Suzuki T, Zeitoun K M, Bulun S E. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.  Cancer Res. 2001;  61 2250-2255
  PubMedGoogle Scholar
• 46 Toda K, Miyahara K, Kawamoto T, Ikeda H, Sagara Y, Shizuta Y. Characterization of a cis-acting regulatory element involved in human aromatase P450 gene expression.  Eur J Biochem. 1992;  205 303-309
  CrossrefPubMedGoogle Scholar
• 47 Yamada K, Harada N, Honda S, Takagi Y. Regulation of placenta-specific expression of the aromatase cytochrome P450 gene: involvement of the trophoblast-specific element binding protein.  J Biol Chem. 1995;  270 25064-25069
  CrossrefPubMedGoogle Scholar
• 48 Sun T, Zhao Y, Fisher C R, Kilgore M, Mendelson C R, Simpson E R. Characterization of cis-acting elements of the human aromatase P450 (CYP19) gene that mediate regulation by retinoids in human choriocarcinoma cells (abstract OR38-8). In: Program & Abstracts of the 10th International Congress of Endocrinology Vol. 1 June 11-14, 1996 San Francisco, CA; Washington, DC; Endocrine Society
  Google Scholar
• 49 Stephanon A, Sarlis N J, Richards R, Handwerger S. Expression of retinoic acid receptor subtypes and cellualr retinoic acid binding protein II in MRNAs during differentiation of human trophoblast cells.  Biochem Biophys Res Commun. 1994;  202 772-780
  CrossrefPubMedGoogle Scholar
• 50 Barak Y, Nelson M C, Ong E S et al.. PPAR gamma is required for placental, cardiac, and adipose tissue development.  Mol Cell. 1999;  4 585-595
  CrossrefPubMedGoogle Scholar
• 51 Jiang B, Kamat A, Mendelson C R. Hypoxia prevents induction of aromatase expression in human trophoblasts: potential inhibitory role of the hypoxia-inducible transcription factor Mash-2 (mammalian achaete-scute homologous protein-2).  Mol Endocrinol. 2000;  14 1661-1673
  CrossrefPubMedGoogle Scholar
• 52 Kamat A, Graves K H, Smith M E, Richardson J A, Mendelson C R. A 500-bp region, approximately 40 kb upstream of the human CYP19 (aromatase) gene, mediates placenta-specific expression in transgenic mice.  Proc Natl Acad Sci USA. 1999;  96 4575-4580
  CrossrefPubMedGoogle Scholar
• 53 Smith E P, Boyd J, Frank G R et al.. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man.  N Engl J Med. 1994;  331 1056-1061
  CrossrefPubMedGoogle Scholar
• 54 Carani C, Qin K, Simoni M et al.. Aromatase deficiency in the male: effect of testosterone and estradiol treatment.  N Engl J Med. 1997;  337 91-95
  CrossrefPubMedGoogle Scholar
• 55 Mullis P E, Yoshimura N, Kuhlmann B, Lippuner K, Jaeger P, Harada H. Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450_arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood.  J Clin Endocrinol Metab. 1997;  82 1739-1745
  CrossrefPubMedGoogle Scholar
• 56 Sasano H, Uzuki M, Sawai T et al.. Aromatase in bone tissue.  J Bone Miner Res. 1997;  12 1416-1423
  PubMedGoogle Scholar
• 57 Shozu M, Simpson E R. Aromatase expression of human osteoblast-like cells.  Mol Cell Endocrinol. 1998;  139 117-129
  CrossrefPubMedGoogle Scholar
• 58 Sasano H, Frost A R, Saitoh R et al.. Aromatase and 17β-hydroxysteroid dehydrogenase type 1 in human breast carcinoma.  J Clin Endocrinol Metab. 1996;  81 4042-4046
  CrossrefPubMedGoogle Scholar
• 59 Lea C K, Ebrahim H, Tennant S, Flanagan A M. Aromatase cytochrome P450 transcripts are detected in fractured human bone but not in normal skeletal tissue.  Bone. 1997;  21 433-440
  CrossrefPubMedGoogle Scholar
• 60 Lauber M E, Lichtensteiger W. Pre- and postnatal ontogeny of aromatase cytochrome P450 messenger RNA expression in the male rat brain studied by in situ hybridization.  Endocrinology. 1994;  135 1661-1668
  CrossrefPubMedGoogle Scholar
• 61 Wagner C K, Morrell J I. Neuroanatomical distribution of aromatase in RNA in the rat brain: indications of regional regulation.  J Steroid Biochem Mol Biol. 1997;  61 307-314
  CrossrefPubMedGoogle Scholar
• 62 Sasano H, Takashashi K, Satoh F, Nagura H, Harada N. Aromatase in the central nervous system.  Clin Endocrinol (Oxf). 1998;  48 325-329
  CrossrefPubMedGoogle Scholar
• 63 Abdelgadir S E, Resko J A, Ojeda S R, Lephart E D, McPhaul M J, Roselli C E. Androgens regulate aromatase cytochrome P450 messenger ribonucleic acid in the rat brain.  Endocrinology. 1994;  135 395-401
  CrossrefPubMedGoogle Scholar
• 64 Abe-Dohmae S, Takagi Y, Harada N. Autonomous expression of aromatase during development of mouse brain is modulated by neurotransmitters.  J Steroid Biochem Mol Biol. 1997;  61 299-306
  CrossrefPubMedGoogle Scholar
• 65 Lanoux M J, Cleland W H, Mendelson C R, Carr B R, Simpson E R. Factors affecting the conversion of androstenedione to estrogens by human fetal hepatocytes in monolayer culture.  Endocrinology. 1985;  117 361-367
  PubMedGoogle Scholar
• 66 Harada N. A unique aromatase (P450arom) mRNA formed by alternative use of tissue specific exons I in human skin fibroblasts.  Biochem Biophys Res Commun. 1992;  189 1001-1007
  CrossrefPubMedGoogle Scholar
• 67 Toda K, Simpson E R, Mendelson C R, Shizuta Y, Kilgore M W. Expression of the gene encoding aromatase cytochrome P450 (CYP19) in fetal tissues.  Mol Endocrinol. 1994;  8 210-217
  CrossrefPubMedGoogle Scholar
• 68 Zeitoun K, Takayama K, Michael M D, Bulun S E. Stimulation of aromatase promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element.  Mol Endocrinol. 1999;  13 239-253
  CrossrefPubMedGoogle Scholar
• 69 Harada N, Sasano H, Murakami H, Ohkuma T, Nagura H, Takagi Y. Localized expression of aromatase in human vascular tissues.  Circ Res. 1999;  84 1285-1291
  PubMedGoogle Scholar
• 70 Sasano H, MuraKami H, Shizawa S, Satomi S, Nagura H, Harada N. Aromatase and sex steroid receptors in human vena cava.  Endocr J. 1999;  46 233-242
  PubMedGoogle Scholar
• 71 Agarwal V R, Takayama K, Van Wyk J J, Sasano H, Simpson E R, Bulun S E. Molecular basis of severe gynecomatsia associated with aromatase expression in a fibrolamellar hepatocellular carcinoma.  J Clin Endocrinol Metab. 1998;  83 1797-1800
  CrossrefPubMedGoogle Scholar
• 72 Bulun S E, Rosenthal I M, Brodie A M et al.. Use of tissue-specific promoters in the regulation of aromatase cytochrome P450 gene expression in human testicular and ovarian sex cord tumors as well as in normal fetal and adult gonads.  J Clin Endocrinol Metab. 1994;  78 1616-1621
  CrossrefPubMedGoogle Scholar
• 73 Young J, Bulun S E, Agarwal V, Couzinet B, Mendelson C R. Aromatase expression in a feminizing adrenocortical tumor.  J Clin Endocrinol Metab. 1996;  81 3173-3176
  CrossrefPubMedGoogle Scholar
• 74 Bulun S E, Economos K, Miller D, Simpson E R. CYP19 (aromatase) gene expression in human malignant endometrial tumors.  J Clin Endocrinol Metab. 1994;  79 1831-1834
  CrossrefPubMedGoogle Scholar
• 75 Noble L S, Simpson E R, Johns A, Bulun S E. Aromatase expression in endometriosis.  J Clin Endocrinol Metab. 1996;  81 174-179
  CrossrefPubMedGoogle Scholar
• 76 Naftolin F, Ryan K J, Davies I J et al.. The formation of estrogens by central neuroendocrine tissues.  Recent Prog Horm Res. 1975;  31 295-319
  PubMedGoogle Scholar
• 77 Siiteri P K, MacDonald P C. Role of extraglandular estrogen in human endocrinology. In: Green RO, Astwood EB Handbook of Physiology. Vol. 2 American Physiological Society 1973: 619-629
  Google Scholar
• 78 Melton L J. Epidemiology of spinal osteoporosis.  Spine. 1997;  22 2S-11S
  CrossrefPubMedGoogle Scholar
• 79 Huang Z, Hankinson S E, Colditz G A et al.. Dual effects of weight and weight gain on breast cancer risk.  JAMA. 1997;  278 1407-1411
  CrossrefPubMedGoogle Scholar
• 80 Hemsell D L, Edman C D, Marks J F, Siiteri P K, MacDonald P C. Plasma precursors of estrogen, II: Correlation of the extent of conversion of plasma androstenedione to estrone with age.  J Clin Endocrinol Metab. 1974;  38 476-479
  PubMedGoogle Scholar
• 81 Tsai-Morris C H, Aquilana D R, Dufau M L. Cellular localisation of rat testicular aromatase activity during development.  Endocrinology. 1985;  116 38-46
  PubMedGoogle Scholar
• 82 Nitta H, Bunick D, Hess R A et al.. Germ cells of the mouse testis express P450 aromatase.  Endocrinology. 1993;  132 1396-1401
  CrossrefPubMedGoogle Scholar
• 83 Morishima A, Grumbach M M, Simpson E R, Fisher C, Qin M. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of oestrogens.  J Clin Endocrinol Metab. 1995;  80 3689-3698
  CrossrefPubMedGoogle Scholar
• 84 Toda K, Okada T, Akira S et al.. Oestrogen at the neonatal stage is critical for reproductive ability of male mice as revealed by supplementation with 17β-oestradiol to aromatase gene (Cyp19) knockout mice.  J Endocrinol. 2001;  168 455-463
  CrossrefPubMedGoogle Scholar
• 85 Robertson K M, Simpson E R, Lacham-Kaplan O, Jones M EE. Characterization of the fertility of the male aromatase knockout (ArKO) mouse.  J Androl. 2001;  22 825-830
  PubMedGoogle Scholar
• 86 Labrie F, Belanger A, Luu-The V et al.. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging.  Steroids. 1998;  63 322-328
  CrossrefPubMedGoogle Scholar
• 87 Corbould A M, Judd S J, Rodgers R J. Expression of types 1,2 and 3 β-hydroxysteroid dehydrogenase in subcutaneous abdominal and intra-abdominal adipose tissue of women.  J Clin Endocrinol Metab. 1998;  83 187-194
  CrossrefPubMedGoogle Scholar
• 88 Pasqualini J R, Chetrite G, Blacker C et al.. Concentrations of estrone, estradiol and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients.  J Clin Endocrinol Metab. 1996;  81 1460-1464
  CrossrefPubMedGoogle Scholar

 Professor
Evan R Simpson

Monash Medical Centre, Level 4, Block E, Prince Henry's Institute of Medical Research

P.O. Box 5152, 246 Clayton Road, Clayton

Victoria 3168, Australia